Mid-Term Outcomes of Valve-Sparing Repair With Intraoperative Balloon Dilation in Tetralogy of Fallot.

Morgan K Moroi, Iris Feng, Alice V Vinogradsky, Christine G Yang, Stephanie N Nguyen, David M Kalfa, Andrew B Goldstone, Emile A Bacha
{"title":"Mid-Term Outcomes of Valve-Sparing Repair With Intraoperative Balloon Dilation in Tetralogy of Fallot.","authors":"Morgan K Moroi, Iris Feng, Alice V Vinogradsky, Christine G Yang, Stephanie N Nguyen, David M Kalfa, Andrew B Goldstone, Emile A Bacha","doi":"10.1177/21501351251321528","DOIUrl":null,"url":null,"abstract":"<p><p>BackgroundLate sequelae associated with chronic severe pulmonary regurgitation (PR) following transannular patch (TAP) repair of tetralogy of Fallot (TOF) have driven the use of alternative approaches. This study investigates mid-term pulmonic valve (PV) durability in TOF patients who underwent valve-sparing repair with intraoperative balloon dilation (VS-IBD).MethodsBetween 2010 and 2022, 139 TOF patients underwent VS-IBD (n = 66) or TAP (n = 73) repair at a single institution. Patients who underwent VS repair without IBD were excluded. Baseline differences were balanced by inverse probability of treatment weighting (IPTW). Primary outcome was freedom from reintervention, with median follow-up of 4.6 years.ResultsValve-sparing repair with intraoperative balloon dilation patients were older (117 vs 64 days, <i>P</i> = .001) with higher PV annulus z-scores (-2.26 vs -2.62, <i>P</i> = .001) compared with TAP patients. After IPTW, VS-IBD patients had a higher reintervention rate (12.6% vs 2.2%, <i>P</i> = .028). At five years, 37/66 (56%) of VS-IBD patients remained free from ≥ moderate PR and 56/66 (85%) free from ≥ moderate pulmonic stenosis (PS). At the latest follow-up, VS-IBD patients demonstrated less right ventricular (RV) dilation (severe: 1.0% vs 15.5%, <i>P</i> = .002) and similar RV function (normal: 88.0% vs 91.8%, <i>P</i> = .273) as their TAP counterparts. In multivariable Cox analysis of VS-IBD patients, female sex (hazard ratio, HR [95% confidence interval, CI]: 4.4 [1.5, 13.2], <i>P</i> = .008) and preoperative PV z-score -2.67 to -2.18 (HR [95% CI]: 5.7 [1.6, 19.6], <i>P</i> = .006) were risk factors for developing ≥ moderate PR.ConclusionsDespite a higher early reintervention rate, the trade-off for VS-IBD patients appears to be better-preserved valve competency overall, as well as less adverse RV remodeling.</p>","PeriodicalId":94270,"journal":{"name":"World journal for pediatric & congenital heart surgery","volume":" ","pages":"21501351251321528"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World journal for pediatric & congenital heart surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/21501351251321528","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

BackgroundLate sequelae associated with chronic severe pulmonary regurgitation (PR) following transannular patch (TAP) repair of tetralogy of Fallot (TOF) have driven the use of alternative approaches. This study investigates mid-term pulmonic valve (PV) durability in TOF patients who underwent valve-sparing repair with intraoperative balloon dilation (VS-IBD).MethodsBetween 2010 and 2022, 139 TOF patients underwent VS-IBD (n = 66) or TAP (n = 73) repair at a single institution. Patients who underwent VS repair without IBD were excluded. Baseline differences were balanced by inverse probability of treatment weighting (IPTW). Primary outcome was freedom from reintervention, with median follow-up of 4.6 years.ResultsValve-sparing repair with intraoperative balloon dilation patients were older (117 vs 64 days, P = .001) with higher PV annulus z-scores (-2.26 vs -2.62, P = .001) compared with TAP patients. After IPTW, VS-IBD patients had a higher reintervention rate (12.6% vs 2.2%, P = .028). At five years, 37/66 (56%) of VS-IBD patients remained free from ≥ moderate PR and 56/66 (85%) free from ≥ moderate pulmonic stenosis (PS). At the latest follow-up, VS-IBD patients demonstrated less right ventricular (RV) dilation (severe: 1.0% vs 15.5%, P = .002) and similar RV function (normal: 88.0% vs 91.8%, P = .273) as their TAP counterparts. In multivariable Cox analysis of VS-IBD patients, female sex (hazard ratio, HR [95% confidence interval, CI]: 4.4 [1.5, 13.2], P = .008) and preoperative PV z-score -2.67 to -2.18 (HR [95% CI]: 5.7 [1.6, 19.6], P = .006) were risk factors for developing ≥ moderate PR.ConclusionsDespite a higher early reintervention rate, the trade-off for VS-IBD patients appears to be better-preserved valve competency overall, as well as less adverse RV remodeling.

法洛四联症术中球囊扩张保瓣修复术的中期疗效。
经环补片(TAP)修复法洛四联症(TOF)后与慢性严重肺反流(PR)相关的晚期后遗症已经推动了替代方法的使用。本研究探讨了采用术中球囊扩张术(VS-IBD)保留瓣膜修复的TOF患者的中期肺动脉瓣(PV)耐久性。方法2010年至2022年间,139例TOF患者在同一家机构接受了VS-IBD (n = 66)或TAP (n = 73)修复。没有IBD的接受VS修复的患者被排除在外。基线差异通过治疗加权逆概率(IPTW)来平衡。主要终点为无再干预,中位随访时间为4.6年。结果与TAP患者相比,术中气囊扩张保留瓣膜修复的患者年龄较大(117天vs 64天,P = 0.001), PV环z-评分较高(-2.26 vs -2.62, P = 0.001)。IPTW后,vs - ibd患者的再干预率更高(12.6% vs 2.2%, P = 0.028)。在5年时,37/66(56%)的VS-IBD患者没有≥中度PR, 56/66(85%)没有≥中度肺动脉狭窄(PS)。在最近的随访中,vs - ibd患者的右心室(RV)扩张较小(重度:1.0% vs 15.5%, P = 0.002), RV功能与TAP患者相似(正常:88.0% vs 91.8%, P = 0.273)。在VS-IBD患者的多变量Cox分析中,女性(风险比,HR[95%置信区间,CI]: 4.4 [1.5, 13.2], P = 0.008)和术前PV z评分-2.67至-2.18 (HR [95% CI]: 5.7 [1.6, 19.6], P = 0.006)是发生≥中度pr的危险因素。结论尽管早期再干预率较高,但VS-IBD患者的权衡似乎总体上保留了更好的瓣膜功能,以及更少的不良RV重构。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信